PacBio Reports 18 Percent Q2 Revenue Drop, Books Seven Systems Orders | GenomeWeb

NEW YORK (GenomeWeb News) – Pacific Biosciences reported after the close of market on Thursday that while its second quarter 2013 revenues dropped roughly 18 percent year over year, its revenues grew 7 percent sequentially.

The Menlo Park, Calif.-based single-molecule sequencing technologies firm reported total revenues of $6 million for the three months ended June 30, compared to $7.3 million in the second quarter of 2012, and $5.6 million in the first quarter of 2013. It fell just shy of the consensus Wall Street estimate for revenues of $6.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.